pCMX-Gal4-TEAD2 Citations (5)

Originally described in: TEAD mediates YAP-dependent gene induction and growth control.
Zhao B, Ye X, Yu J, Li L, Li W, Li S, Yu J, Lin JD, Wang CY, Chinnaiyan AM, Lai ZC, Guan KL Genes Dev. 2008 Jul 15. 22(14):1962-71. PubMed Journal

---

Articles Citing pCMX-Gal4-TEAD2

Articles
Mediated nuclear import and export of TAZ and the underlying molecular requirements. Kofler M, Speight P, Little D, Di Ciano-Oliveira C, Szaszi K, Kapus A. Nat Commun. 2018 Nov 23;9(1):4966. doi: 10.1038/s41467-018-07450-0. PubMed
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking. Smith SA, Sessions RB, Shoemark DK, Williams C, Ebrahimighaei R, McNeill MC, Crump MP, McKay TR, Harris G, Newby AC, Bond M. J Med Chem. 2019 Feb 14;62(3):1291-1305. doi: 10.1021/acs.jmedchem.8b01402. Epub 2019 Jan 31. PubMed
Lats1/2 Sustain Intestinal Stem Cells and Wnt Activation through TEAD-Dependent and Independent Transcription. Li Q, Sun Y, Jarugumilli GK, Liu S, Dang K, Cotton JL, Xiol J, Chan PY, DeRan M, Ma L, Li R, Zhu LJ, Li JH, Leiter AB, Ip YT, Camargo FD, Luo X, Johnson RL, Wu X, Mao J. Cell Stem Cell. 2020 May 7;26(5):675-692.e8. doi: 10.1016/j.stem.2020.03.002. Epub 2020 Apr 6. PubMed
Multiomics characterization of mouse hepatoblastoma identifies yes-associated protein 1 target genes. Rodriguez TC, Kwan SY, Smith JL, Dadafarin S, Wu CH, Sontheimer EJ, Xue W. Hepatology. 2022 Aug 6. doi: 10.1002/hep.32713. PubMed
Structure-based discovery of a novel small-molecule inhibitor of TEAD palmitoylation with anticancer activity. Gridnev A, Maity S, Misra JR. Front Oncol. 2022 Nov 29;12:1021823. doi: 10.3389/fonc.2022.1021823. eCollection 2022. PubMed

If you have published an article using this material, please email us at to have your article added to this page.